A detailed history of Empirical Finance, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Empirical Finance, LLC holds 4,355 shares of UTHR stock, worth $1.52 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,355
Previous 4,033 7.98%
Holding current value
$1.52 Million
Previous $926,000 49.78%
% of portfolio
0.09%
Previous 0.06%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$228.26 - $319.04 $73,499 - $102,730
322 Added 7.98%
4,355 $1.39 Million
Q1 2024

May 06, 2024

BUY
$210.76 - $249.51 $3,372 - $3,992
16 Added 0.4%
4,033 $926,000
Q3 2023

Nov 02, 2023

BUY
$211.82 - $248.24 $56,555 - $66,280
267 Added 7.12%
4,017 $907,000
Q2 2023

Jul 27, 2023

BUY
$205.19 - $232.99 $398,478 - $452,466
1,942 Added 107.41%
3,750 $827,000
Q4 2022

Jan 24, 2023

BUY
$205.95 - $280.43 $2,471 - $3,365
12 Added 0.67%
1,808 $503,000
Q3 2022

Nov 04, 2022

BUY
$203.3 - $244.17 $365,126 - $438,529
1,796 New
1,796 $376,000
Q4 2021

Feb 04, 2022

SELL
$184.32 - $216.08 $811,008 - $950,752
-4,400 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $968,905 - $1.16 Million
-5,387 Reduced 55.04%
4,400 $812,000
Q2 2021

Aug 10, 2021

SELL
$170.47 - $211.93 $2.1 Million - $2.61 Million
-12,324 Reduced 55.74%
9,787 $1.76 Million
Q3 2020

Oct 28, 2020

SELL
$99.9 - $121.13 $302,896 - $367,266
-3,032 Reduced 12.06%
22,111 $2.23 Million
Q3 2020

Oct 26, 2020

SELL
$99.9 - $121.13 $76,223 - $92,422
-763 Reduced 2.95%
25,143 $2.01 Million
Q2 2020

Jul 20, 2020

SELL
$92.74 - $125.82 $438,474 - $594,876
-4,728 Reduced 18.41%
20,957 $3.14 Million
Q2 2020

Jul 20, 2020

BUY
$92.74 - $125.82 $458,970 - $622,683
4,949 Added 23.62%
25,906 $3.14 Million
Q1 2020

Apr 16, 2020

BUY
$79.39 - $115.35 $312,399 - $453,902
3,935 Added 18.09%
25,685 $2.44 Million
Q4 2019

Jan 27, 2020

SELL
$78.31 - $95.34 $265,705 - $323,488
-3,393 Reduced 13.49%
21,750 $1.92 Million
Q3 2019

Oct 30, 2019

BUY
$74.85 - $85.99 $1.26 Million - $1.45 Million
16,809 Added 201.69%
25,143 $2.01 Million
Q2 2019

Jul 09, 2019

BUY
$76.06 - $120.81 $3,346 - $5,315
44 Added 0.53%
8,334 $651,000
Q1 2019

May 10, 2019

BUY
$107.15 - $126.84 $888,273 - $1.05 Million
8,290 New
8,290 $973,000
Q4 2018

Jan 22, 2019

SELL
$101.4 - $128.73 $2.12 Million - $2.69 Million
-20,867 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$113.81 - $129.46 $443,403 - $504,376
3,896 Added 22.96%
20,867 $2.67 Million
Q2 2018

Jul 09, 2018

BUY
$101.14 - $118.31 $877,996 - $1.03 Million
8,681 Added 104.72%
16,971 $1.92 Million
Q1 2018

May 10, 2019

SELL
$107.21 - $151.94 $1.68 Million - $2.38 Million
-15,647 Reduced 65.37%
8,290 $973,000
Q1 2018

Apr 25, 2018

BUY
$107.21 - $151.94 $1.61 Million - $2.29 Million
15,043 Added 169.14%
23,937 $2.69 Million
Q4 2017

Feb 01, 2018

SELL
$118.58 - $151.28 $795,908 - $1.02 Million
-6,712 Reduced 43.01%
8,894 $1.32 Million
Q3 2017

Oct 31, 2017

BUY
$114.6 - $136.81 $136,374 - $162,803
1,190 Added 8.25%
15,606 $1.83 Million
Q2 2017

Aug 10, 2017

BUY
N/A
14,416
14,416 $1.87 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.